1. European Medicines Agency. Inflectra Summary of Product Characteristics. 2019. https://www.ema.europa.eu/en/documents/product-information/inflectra-epar-product-information_en.pdf. Accessed 12 Sept 2019.
2. European Medicines Agency. Remsima Summary of Product Characteristics. 2019. https://www.ema.europa.eu/en/documents/product-information/remsima-epar-product-information_en.pdf. Accessed 12 Sept 2019.
3. US Food and Drug Administration. Inflectra Prescribing Information. 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125544s009lbl.pdf. Accessed 12 Sept 2019.
4. Generics and Biosimilars Initiative. Biosimilar monoclonal antibody approved in Korea. 2012. https://www.gabionline.net/Biosimilars/News/Biosimilar-monoclonal-antibody-approved-in-Korea. Accessed 21 Aug 2019.
5. European Medicines Agency. Remicade Summary of Product Characteristics. 2019. https://www.ema.europa.eu/en/documents/product-information/remicade-epar-product-information_en.pdf. Accessed 12 Sept 2019.